Trial · NCT07206290
Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease
NCT07206290, Phase 2, Not yet recruiting, University Medical Center Groningen
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease. Trials, record NCT07206290. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07206290
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Albuminuria Reduction Study With Survodutide Treatment in Kidney Disease
- NCT number
- NCT07206290
- Status
- Not yet recruiting
- Phases
- Phase 2
- Enrollment
- 120 participants, estimated
- Lead sponsor
- University Medical Center Groningen
- Conditions
- Chronic Kidney Disease
- Interventions
- Survodutide (BI 456906), Placebo
- First posted
- 2025-10-03
- Last updated
- 2025-10-03
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in first morning void UACR | From baseline to week 32/36 | Average of first morning void urine samples collected at week 32 and 36 will be used to decrease random day-to-day variability and increase precision (and statistical power). |
| Secondary | eGFR (creatinine, cystatin C, and creatinine-cystatin C) | From baseline to week 36 | |
| Secondary | Iohexol measured GFR | From baseline to week 36 | Subset of 60 participants |
| Secondary | UACR and eGFR during 4-week wash-out | From week 36 to 40 | |
| Secondary | Perirenal and renal sinus fat measured by MRI | From baseline to week 36 | Same subset of 60 participants with Iohexol GFR |
| Secondary | Subcutaneous and visceral fat assessed by MRI | From baseline to week 36 | Same subset of 60 participants with Iohexol GFR |
| Secondary | Body weight | From baseline to week 36 | |
| Secondary | Waist circumference | From baseline to week 36 | |
| Secondary | Systolic and diastolic blood pressure | From baseline to week 36 | |
| Other | HbA1c | From baseline to week 36 |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07206290
GET https://conductscience.org/api/trials/v1/NCT07206290/registered